All In MedTech

FDA Clearance Tracker · P990026-S019

GLUCOWATCH G2 BIOGRAPHER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 28, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 28, 2003

Approved

Time to decision

52 days

Received Jul 7, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P990026-S019
Device name
GLUCOWATCH G2 BIOGRAPHER
Applicant
Animas Corp.
Applicant location
West Chester, PA
Received
Jul 7, 2003
Decided
Aug 28, 2003
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P990026

Device type

Device class
Class III

Every decision under product code NCT

FDA's approval statement

As written in FDA's record.

APPROVAL OF A POST-APPROVAL STUDY PROTOCOL FOR THE DEVICE.

Source documents

Other decisions for Animas Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.